Connect with us
Spanish pharma companies started the year maintaining the red of the previous year. In Q1, the aggregate capitalization registered a drop of 10.57%, with values such...
Oryzon plans to maintain its share capital at €3.03 million and seek admission for new shares on Madrid, Barcelona, Bilbao, and Valencia Stock Exchanges. The biopharmaceutical...
The gross operating result (Ebitda) reached €97.1 million in the first half of 2023, 16% less than in the first six months of 2022. Operating income...
The demand for products indicated against diabetes has increased. Large groups in the sector announced new investment plans to grow in this segment. However, not everything...
This alliance focuses on said patent for the preparation of a preclinical antibody program against the IL-18 binding protein. Under the terms of the agreement, Compugen...
Authorities are focusing on addressing challenges related to integrating AI tools. The first initiative involves supporting AI in the life cycle of medicines. The Committee for...
Within the health sector, 20% of investment in R&D came from the ten largest companies by investment, which allocated €53.9 billion, €10 billion more than the...
According to the European Biotech index of Cphi, the largest pharmaceutical hub in the world, Barcelona is already the second best European location for investment in...
The pharmaceutical industry invested €175 million in basic research, marking an 11% growth from 2021. This allocation represents one in eight euros for biomedical R&D, emphasizing...
The Trak Health Solutions application seeks to offer health professionals and clients an advanced platform to manage rehabilitation treatments. As a novelty, this service integrates telecare...
 |
|
 |  |
 |
|